Pai et al. showed that the methylation level of an enhancer within the IGF-2 gene, which targets the nearby tyrosine hydroxylase (TH) gene responsible for dopamine synthesis, was reduced in the frontal cortex of schizophrenia patients [23]. The gene discussed is IGF2; the disease is schizophrenia.